SavedAdd your journal

Journals / ANKEM Dergisi / 2011 / Cilt: 25 - Sayı: 3

Antimicrobial resistance and prevention policies

Antimikrobiyal direnç ve önleme politikaları

Halis AKALIN
Pages
190–195
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Antibiotic stewardship programme should include multidiciplinary structure, programmatic and prospective interventions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The increase of antibiotic resistance causes severe morbidity and mortality.
📊
Key Findings & Data:The factors that play roles for the development and emergence of antibiotic resistance includes usage of antibiotics, infection control insufficiency and environment.
💡
Conclusion & Impact:Antibiotic stewardship programme should include multidiciplinary structure, programmatic and prospective interventions.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The increase of antibiotic resistance causes severe morbidity and mortality. The factors that play roles for the development and emergence of antibiotic resistance includes usage of antibiotics, infection control insufficiency and environment. Optimization of treatment duration is very important for prevention of resistance. Procalcitonin studies which was conducted in recent years carries hope for future in the optimization of treatment duration. Antibiotic resistance, patient safety and cost problems indicate the need of antibiotic stewardship programmes. Antibiotic stewardship programme should include multidiciplinary structure, programmatic and prospective interventions.

Özet

Antibiyotiklere karşı direnç artışı ciddi morbidite ve mortaliteye neden olmaktadır. Antibiyotik direncinin gelişiminde ve ortaya çıkmasında rol oynayan faktörler; antibiyotik kullanımı, infeksiyon kontrolü yetersizliği ve çevredir. Antibiyotik tedavi sürelerinin optimizasyonu da direncin önlenmesinde çok önemlidir. Son yıllarda prokalsitonin ile yapılan çalışmalar tedavi sürelerinin optimizasyonunda gelecek için ümit taşımaktadır. Antibiyotik direnci, hasta güvenliği ve maliyet problemi antibiyotik kullanımının yönetimine olan gereksinimi gündeme getirmektedir. Antibiyotik kullanımının yönetimi; multidisipliner, programlı ve ileriye dönük müdaheleleri içeren bir yapıda olmalıdır.

🔖

Cite This Article

AKALIN, H. (2011). Antimicrobial resistance and prevention policies. ANKEM Dergisi, Cilt: 25 - Sayı: 3, 190–195. https://ajindex.com/articles/355060

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Akalın H. Yoğun bakımlarda direnç gelişmesini önleme yöntemleri, ANKEM Derg 2001;15(3):425-36
  2. Akalın H, Kahveci F, Özakın C et al. Influences of alternate therapy protocol and continuous infectious disease consultation on antibiotic susceptibility in ICU, Intensive Care Med 1999;25(9):1010-2
  3. Arda B, Sipahi OR, Yamazhan T et al. Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance, J Infect 2007;55(1):41-8. http://dx.doi.org/10.1016/j.jinf.2007.02.014 PMid:17512598 4. Azap A, Topçuoğlu A, Yeşilkaya A et al. The effect of a nationwide antibiotic restriction policy on antibiotic usage in a stem cell transplantation unit, Turk J Haematol 2005;22(2):87-90
  4. Bergstrom CT, Lo M, Lipsitch M. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals, Proc Natl Acad Sci USA 2004;101(36):13285-90. http://dx.doi.org/10.1073/pnas.0402298101 PMid:15308772 PMCid:516561 6. Cunha BA. Antibiotic resistance. Control strategies, Crit Care Clin 1998;14(2):309-27.
  5. Cunha BA. Effective antibiotic-resistance control strategies, Lancet 2001;357(9265):1307-8.
  6. Dellit TH, Owens RC, McGowan JE et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for developing an institutional program to enhance antimicrobial stewardship, Clin Infect Dis 2007;44(2):159-77. http://dx.doi.org/10.1086/510393 PMid:17173212 9. Dominguez EA, Smith TL, Reed E, Sanders CC, Sanders WE. A pilot study of antibiotic cycling in a hematology-oncology unit, Infect Control Hosp Epidemiol 2000;21(Suppl 1):4-8. http://dx.doi.org/10.1086/503166 PMid:10654628 10. Geissler A, Gerbeaux P, Granier I, Blanc P, Facon K, Durand-Gasselin J. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs, Intensive Care Med 2003;29(1):49-54. PMid:12528022 11. Gerding DN, Larson TA, Hughes RA et al. Aminoglycoside resistance and aminoglycoside usage: 10 years of experience in one hospital, Antimicrob Agents Chemother 1991;35(7):1284-90. PMid:1929283 PMCid:245159 12. Giamarellou H, Antoniadou A. The effect of monitoring of antibiotic use on decreasing antibiotic resistance in the hospital, Symposium on antibiotic resistance: Origins, evolution, selection and spread, Ciba